NEW YORK (GenomeWeb) – Following a bankruptcy proceeding that began a few years ago, ZyGem has found a home as part of a new UK company that is taking a chance on the firm and its affiliate Microlab, intent on focusing on ZyGem's unique sample-prep capabilities with a longer-term goal of expanding on work toward a platform for the forensics market.

ZyGem and Microlab are now part of MicroGem International, a firm publicly traded in the UK that acquired the assets of ZyGem and MicroLab last year.